Estimated using RAND 2024 commercial-to-Medicare ratios. Actual prices vary by insurer, plan, and facility.
Top Providers in California
| Provider | Medicare | Services |
|---|---|---|
| Quest Diagnostics Nichols Institute | $29.50 | 300 |
| Neogenomics Laboratories Inc | $27.23 | 277 |
| Neogenomics Laboratories Inc | $28.38 | 87 |
| Laboratory Corporation Of America | $24.51 | 71 |
| Neogenomics Laboratories Inc | $27.61 | 47 |
| Kitahara, Sumire M.D. | $30.18 | 32 |
| Neogenomics Laboratories Inc | $29.50 | 24 |
| Aoun, Patricia MD | $29.52 | 22 |
| Rawson, Robin M.D. | $28.78 | 21 |
| Siami-Namini, Koushan MD | $28.78 | 18 |
| Lopategui, Jean Marie MD | $30.18 | 13 |
California Pricing in Context
In California, CPT code 88187 (Flow Cytometry Technique For Dna Or Cell Analysis, 2 To 8 Markers) carries an average Medicare payment of $28.23 — 4% above the national benchmark of $27.09. 118 providers across the state submitted claims for this procedure in 2023, performing 1.6K total services. Individual payments in CA ranged from N/A at the low end to N/A at the high end, reflecting differences in provider setting (office vs. facility), modifiers, and the specific geographic locality code applied within the state.
The average billed charge in California is $232.33, which is the figure uninsured patients would most likely encounter before any negotiation or charity discount. Medicare, by statute, only reimburses the allowed amount — the balance between billed and paid is written off under provider participation agreements. Insured patients generally pay a negotiated rate that falls between these two figures; the exact amount depends on plan design, deductible status, and in-network participation. Because California sits above the national Medicare average, commercial rates in the state may also run higher than the US median.
Using RAND 2024 commercial-to-Medicare ratios for Genetic/Molecular Test procedures, the estimated commercial insurance price in California lands near $87.92, with self-pay cash prices typically around $91.36. Before scheduling, patients can request a Good Faith Estimate under the No Surprises Act, compare cash rates from hospital Machine-Readable Files, and confirm whether the provider is in-network with their specific plan. This page presents CMS reference data for informational use; it does not constitute medical or financial advice.
Frequently Asked Questions
How much does Flow Cytometry Technique For Dna Or Cell Analysis, 2 To 8 Markers cost in California?
The average Medicare payment for Flow Cytometry Technique For Dna Or Cell Analysis, 2 To 8 Markers in California is $28.23, which is 4% above the national average of $27.09. Providers in CA typically bill $232.33 for this procedure.
What does Flow Cytometry Technique For Dna Or Cell Analysis, 2 To 8 Markers cost with insurance in California?
With commercial insurance in California, Flow Cytometry Technique For Dna Or Cell Analysis, 2 To 8 Markers costs an estimated $87.92. Without insurance, the estimated cash price is $91.36. These estimates are based on RAND 2024 commercial-to-Medicare ratios and vary by insurer, plan, and facility.
How many providers perform Flow Cytometry Technique For Dna Or Cell Analysis, 2 To 8 Markers in California?
118 providers in California billed Medicare for Flow Cytometry Technique For Dna Or Cell Analysis, 2 To 8 Markers in 2023, performing 1.6K total services. Medicare payments ranged from N/A to N/A depending on the provider.
Is Flow Cytometry Technique For Dna Or Cell Analysis, 2 To 8 Markers cheaper in California than the national average?
No — Flow Cytometry Technique For Dna Or Cell Analysis, 2 To 8 Markers costs 4% above the national average in California. The state average Medicare payment is $28.23 compared to $27.09 nationally. Factors like local cost of living, provider competition, and regional Medicare fee schedules all influence state-level pricing.
Related Guides
Related Data Sources
Data from CMS Medicare Physician & Other Practitioners (2023).
Read our methodology — how this data is sourced, computed, and verified.